Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 281

1.

Hypertrophic Cardiomyopathy-Need for Gene-Specific Treatment?-Reply.

Coats CJ, Frenneaux MP, Elliott PM.

JAMA Cardiol. 2019 Jun 12. doi: 10.1001/jamacardio.2019.1766. [Epub ahead of print] No abstract available.

PMID:
31188395
2.

Wave intensity and cognitive decline: where the heart leads the mind follows.

Raphael CE, Frenneaux M.

Eur Heart J. 2019 May 18. pii: ehz307. doi: 10.1093/eurheartj/ehz307. [Epub ahead of print] No abstract available.

PMID:
31102522
3.

Diastolic Ventricular Interaction in Heart Failure With Preserved Ejection Fraction.

Parasuraman SK, Loudon BL, Lowery C, Cameron D, Singh S, Schwarz K, Gollop ND, Rudd A, McKiddie F, Phillips JJ, Prasad SK, Wilson AM, Sen-Chowdhry S, Clark A, Vassiliou VS, Dawson DK, Frenneaux MP.

J Am Heart Assoc. 2019 Apr 2;8(7):e010114. doi: 10.1161/JAHA.118.010114.

4.

Inorganic nitrate, hypoxia, and the regulation of cardiac mitochondrial respiration-probing the role of PPARα.

Horscroft JA, O'Brien KA, Clark AD, Lindsay RT, Steel AS, Procter NEK, Devaux J, Frenneaux M, Harridge SDR, Murray AJ.

FASEB J. 2019 Jun;33(6):7563-7577. doi: 10.1096/fj.201900067R. Epub 2019 Mar 14.

5.

Effect of Trimetazidine Dihydrochloride Therapy on Exercise Capacity in Patients With Nonobstructive Hypertrophic Cardiomyopathy: A Randomized Clinical Trial.

Coats CJ, Pavlou M, Watkinson OT, Protonotarios A, Moss L, Hyland R, Rantell K, Pantazis AA, Tome M, McKenna WJ, Frenneaux MP, Omar R, Elliott PM.

JAMA Cardiol. 2019 Feb 6. doi: 10.1001/jamacardio.2018.4847. [Epub ahead of print]

PMID:
30725091
6.

The interplay between metabolic alterations, diastolic strain rate and exercise capacity in mild heart failure with preserved ejection fraction: a cardiovascular magnetic resonance study.

Mahmod M, Pal N, Rayner J, Holloway C, Raman B, Dass S, Levelt E, Ariga R, Ferreira V, Banerjee R, Schneider JE, Rodgers C, Francis JM, Karamitsos TD, Frenneaux M, Ashrafian H, Neubauer S, Rider O.

J Cardiovasc Magn Reson. 2018 Dec 24;20(1):88. doi: 10.1186/s12968-018-0511-6.

7.

Outcome in Dilated Cardiomyopathy Related to the Extent, Location, and Pattern of Late Gadolinium Enhancement.

Halliday BP, Baksi AJ, Gulati A, Ali A, Newsome S, Izgi C, Arzanauskaite M, Lota A, Tayal U, Vassiliou VS, Gregson J, Alpendurada F, Frenneaux MP, Cook SA, Cleland JGF, Pennell DJ, Prasad SK.

JACC Cardiovasc Imaging. 2018 Sep 6. pii: S1936-878X(18)30670-3. doi: 10.1016/j.jcmg.2018.07.015. [Epub ahead of print]

8.

Nitrosative Stress as a Modulator of Inflammatory Change in a Model of Takotsubo Syndrome.

Surikow SY, Nguyen TH, Stafford I, Chapman M, Chacko S, Singh K, Licari G, Raman B, Kelly DJ, Zhang Y, Waddingham MT, Ngo DT, Bate AP, Chua SJ, Frenneaux MP, Horowitz JD.

JACC Basic Transl Sci. 2018 Apr 18;3(2):213-226. doi: 10.1016/j.jacbts.2017.10.002. eCollection 2018 Apr.

9.

Sex- and age-based differences in the natural history and outcome of dilated cardiomyopathy.

Halliday BP, Gulati A, Ali A, Newsome S, Lota A, Tayal U, Vassiliou VS, Arzanauskaite M, Izgi C, Krishnathasan K, Singhal A, Chiew K, Gregson J, Frenneaux MP, Cook SA, Pennell DJ, Collins P, Cleland JGF, Prasad SK.

Eur J Heart Fail. 2018 Oct;20(10):1392-1400. doi: 10.1002/ejhf.1216. Epub 2018 Jun 3.

10.

Multicenter Randomized Controlled Crossover Trial Comparing Hemodynamic Optimization Against Echocardiographic Optimization of AV and VV Delay of Cardiac Resynchronization Therapy: The BRAVO Trial.

Whinnett ZI, Sohaib SMA, Mason M, Duncan E, Tanner M, Lefroy D, Al-Obaidi M, Ellery S, Leyva-Leon F, Betts T, Dayer M, Foley P, Swinburn J, Thomas M, Khiani R, Wong T, Yousef Z, Rogers D, Kalra PR, Dhileepan V, March K, Howard J, Kyriacou A, Mayet J, Kanagaratnam P, Frenneaux M, Hughes AD, Francis DP.

JACC Cardiovasc Imaging. 2018 May 11. pii: S1936-878X(18)30211-0. doi: 10.1016/j.jcmg.2018.02.014. [Epub ahead of print]

11.

Nitrite circumvents platelet resistance to nitric oxide in patients with heart failure preserved ejection fraction and chronic atrial fibrillation.

Borgognone A, Shantsila E, Worrall SM, Prompunt E, Loka T, Loudon BL, Chimen M, Ed Rainger G, Lord JM, Turner A, Nightingale P, Feelisch M, Kirchhof P, Lip GYH, Watson SP, Frenneaux MP, Madhani M.

Cardiovasc Res. 2018 Aug 1;114(10):1313-1323. doi: 10.1093/cvr/cvy087.

12.

A robust and versatile mass spectrometry platform for comprehensive assessment of the thiol redox metabolome.

Sutton TR, Minnion M, Barbarino F, Koster G, Fernandez BO, Cumpstey AF, Wischmann P, Madhani M, Frenneaux MP, Postle AD, Cortese-Krott MM, Feelisch M.

Redox Biol. 2018 Jun;16:359-380. doi: 10.1016/j.redox.2018.02.012. Epub 2018 Feb 19.

13.

Phenotype and Clinical Outcomes of Titin Cardiomyopathy.

Tayal U, Newsome S, Buchan R, Whiffin N, Halliday B, Lota A, Roberts A, Baksi AJ, Voges I, Midwinter W, Wilk A, Govind R, Walsh R, Daubeney P, Jarman JWE, Baruah R, Frenneaux M, Barton PJ, Pennell D, Ware JS, Prasad SK, Cook SA.

J Am Coll Cardiol. 2017 Oct 31;70(18):2264-2274. doi: 10.1016/j.jacc.2017.08.063.

14.

Does cardiac resynchronization therapy restore peripheral circulatory homeostasis?

Ajaero CN, Chong CR, Procter NEK, Liu S, Chirkov YY, Heresztyn T, Chan WPA, Arstall MA, McGavigan AD, Frenneaux MP, Horowitz JD.

ESC Heart Fail. 2018 Feb;5(1):129-138. doi: 10.1002/ehf2.12211. Epub 2017 Oct 13.

15.

Inorganic Nitrate in Angina Study: A Randomized Double-Blind Placebo-Controlled Trial.

Schwarz K, Singh S, Parasuraman SK, Rudd A, Shepstone L, Feelisch M, Minnion M, Ahmad S, Madhani M, Horowitz J, Dawson DK, Frenneaux MP.

J Am Heart Assoc. 2017 Sep 8;6(9). pii: e006478. doi: 10.1161/JAHA.117.006478.

16.

Report from the Annual Conference of the British Society of Echocardiography, November 2016, Queen Elizabeth II Conference Centre, London.

Steeds RP, Cowie MR, Rana BS, Chambers JB, Ray S, Srinivasan J, Schwarz K, Neil CJ, Scally C, Horowitz JD, Frenneaux MP, Pislaru C, Dawson DK, Rothwell OJ, George K, Somauroo JD, Lord R, Stembridge M, Shave R, Hoffman M, Ashley EA, Haddad F, Eijsvogels TMH, Oxborough D, Hampson R, Kinsey CD, Gurunathan S, Vamvakidou A, Karogiannis N, Senior R, Ahmadvazir S, Shah BN, Zacharias K, Bowen D, Robinson S, Ihekwaba U, Parker K, Boyd J, Densem CG, Atkinson C, Hinton J, Gaisie EB, Rakhit DJ, Yue AM, Roberts PR, Thomas D, Phen P, Sibley J, Fergey S, Russhard P.

Echo Res Pract. 2017 Sep 1;4(3):M1. doi: 10.1530/ERP-17-0046. No abstract available.

17.

Author's Reply.

Schwarz K, Ahearn T, Srinivasan J, Neil CJ, Scally C, Rudd A, Jagpal B, Frenneaux MP, Pislaru C, Horowitz JD, Dawson DK.

J Am Soc Echocardiogr. 2017 Oct;30(10):1042. doi: 10.1016/j.echo.2017.07.002. No abstract available.

PMID:
28847560
18.

Comprehensive Echocardiographic and Cardiac Magnetic Resonance Evaluation Differentiates Among Heart Failure With Preserved Ejection Fraction Patients, Hypertensive Patients, and Healthy Control Subjects.

Mordi IR, Singh S, Rudd A, Srinivasan J, Frenneaux M, Tzemos N, Dawson DK.

JACC Cardiovasc Imaging. 2018 Apr;11(4):577-585. doi: 10.1016/j.jcmg.2017.05.022. Epub 2017 Aug 16. Erratum in: JACC Cardiovasc Imaging. 2019 Mar;12(3):576.

19.

Cardiac metabolism - A promising therapeutic target for heart failure.

Noordali H, Loudon BL, Frenneaux MP, Madhani M.

Pharmacol Ther. 2018 Feb;182:95-114. doi: 10.1016/j.pharmthera.2017.08.001. Epub 2017 Aug 15. Review.

PMID:
28821397
20.

Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary intervention.

Campo G, Pavasini R, Morciano G, Lincoff MA, C Gibson M, Kitakaze M, Lonborg J, Ahluwalia A, Ishii H, Frenneaux M, Ovize M, Galvani M, Atar D, Ibanez B, Cerisano G, Biscaglia S, Neil BJ, Asakura M, Engstrom T, Jones DA, Dawson D, Ferrari R, Pinton P, Ottani F.

Data Brief. 2017 Jul 18;14:197-205. doi: 10.1016/j.dib.2017.07.033. eCollection 2017 Oct.

21.

Clinical benefit of drugs targeting mitochondrial function as an adjunct to reperfusion in ST-segment elevation myocardial infarction: A meta-analysis of randomized clinical trials.

Campo G, Pavasini R, Morciano G, Lincoff AM, Gibson CM, Kitakaze M, Lonborg J, Ahluwalia A, Ishii H, Frenneaux M, Ovize M, Galvani M, Atar D, Ibanez B, Cerisano G, Biscaglia S, Neil BJ, Asakura M, Engstrom T, Jones DA, Dawson D, Ferrari R, Pinton P, Ottani F.

Int J Cardiol. 2017 Oct 1;244:59-66. doi: 10.1016/j.ijcard.2017.06.040. Epub 2017 Jun 13. Review.

PMID:
28634037
22.

Assessment of pulmonary artery pressure by echocardiography-A comprehensive review.

Parasuraman S, Walker S, Loudon BL, Gollop ND, Wilson AM, Lowery C, Frenneaux MP.

Int J Cardiol Heart Vasc. 2016 Jul 4;12:45-51. doi: 10.1016/j.ijcha.2016.05.011. eCollection 2016 Sep. Review.

23.

Identification of myocardial diffuse fibrosis by 11 heartbeat MOLLI T 1 mapping: averaging to improve precision and correlation with collagen volume fraction.

Vassiliou VS, Wassilew K, Cameron D, Heng EL, Nyktari E, Asimakopoulos G, de Souza A, Giri S, Pierce I, Jabbour A, Firmin D, Frenneaux M, Gatehouse P, Pennell DJ, Prasad SK.

MAGMA. 2018 Feb;31(1):101-113. doi: 10.1007/s10334-017-0630-3. Epub 2017 Jun 12.

24.

Alterations in Cardiac Deformation, Timing of Contraction and Relaxation, and Early Myocardial Fibrosis Accompany the Apparent Recovery of Acute Stress-Induced (Takotsubo) Cardiomyopathy: An End to the Concept of Transience.

Schwarz K, Ahearn T, Srinivasan J, Neil CJ, Scally C, Rudd A, Jagpal B, Frenneaux MP, Pislaru C, Horowitz JD, Dawson DK.

J Am Soc Echocardiogr. 2017 Aug;30(8):745-755. doi: 10.1016/j.echo.2017.03.016. Epub 2017 Jun 7.

PMID:
28599831
25.

Glycocalyx shedding is markedly increased during the acute phase of Takotsubo cardiomyopathy.

Nguyen TH, Liu S, Ong GJ, Stafford I, Frenneaux MP, Horowitz JD.

Int J Cardiol. 2017 Sep 15;243:296-299. doi: 10.1016/j.ijcard.2017.04.085. Epub 2017 Apr 28.

PMID:
28528983
26.

Association Between Midwall Late Gadolinium Enhancement and Sudden Cardiac Death in Patients With Dilated Cardiomyopathy and Mild and Moderate Left Ventricular Systolic Dysfunction.

Halliday BP, Gulati A, Ali A, Guha K, Newsome S, Arzanauskaite M, Vassiliou VS, Lota A, Izgi C, Tayal U, Khalique Z, Stirrat C, Auger D, Pareek N, Ismail TF, Rosen SD, Vazir A, Alpendurada F, Gregson J, Frenneaux MP, Cowie MR, Cleland JGF, Cook SA, Pennell DJ, Prasad SK.

Circulation. 2017 May 30;135(22):2106-2115. doi: 10.1161/CIRCULATIONAHA.116.026910. Epub 2017 Mar 28.

27.

Human Second Window Pre-Conditioning and Post-Conditioning by Nitrite Is Influenced by a Common Polymorphism in Mitochondrial Aldehyde Dehydrogenase.

Ormerod JO, Evans JD, Contractor H, Beretta M, Arif S, Fernandez BO, Feelisch M, Mayer B, Kharbanda RK, Frenneaux MP, Ashrafian H.

JACC Basic Transl Sci. 2017 Feb 15;2(1):13-21. doi: 10.1016/j.jacbts.2016.11.006. eCollection 2017 Feb.

28.

Development of Fluorinated Analogues of Perhexiline with Improved Pharmacokinetic Properties and Retained Efficacy.

Tseng CC, Noordali H, Sani M, Madhani M, Grant DM, Frenneaux MP, Zanda M, Greig IR.

J Med Chem. 2017 Apr 13;60(7):2780-2789. doi: 10.1021/acs.jmedchem.6b01592. Epub 2017 Mar 21.

PMID:
28277663
29.

Feasibility of cardiovascular magnetic resonance derived coronary wave intensity analysis.

Raphael CE, Keegan J, Parker KH, Simpson R, Collinson J, Vassiliou V, Wage R, Drivas P, Strain S, Cooper R, de Silva R, Stables RH, Di Mario C, Frenneaux M, Pennell DJ, Davies JE, Hughes AD, Firmin D, Prasad SK.

J Cardiovasc Magn Reson. 2016 Dec 9;18(1):93.

30.

A randomized double-blind placebo-controlled crossover trial of sodium nitrate in patients with stable angina INAS.

Schwarz K, Singh S, Parasuraman SK, Bruce M, Shepstone L, Feelisch M, Minnion M, Ahmad S, Horowitz J, Dawson DK, Frenneaux MP.

Future Cardiol. 2016 Nov;12(6):617-626. Epub 2016 Oct 12.

31.

Mechanisms of Myocardial Ischemia in Hypertrophic Cardiomyopathy: Insights From Wave Intensity Analysis and Magnetic Resonance.

Raphael CE, Cooper R, Parker KH, Collinson J, Vassiliou V, Pennell DJ, de Silva R, Hsu LY, Greve AM, Nijjer S, Broyd C, Ali A, Keegan J, Francis DP, Davies JE, Hughes AD, Arai A, Frenneaux M, Stables RH, Di Mario C, Prasad SK.

J Am Coll Cardiol. 2016 Oct 11;68(15):1651-1660. doi: 10.1016/j.jacc.2016.07.751.

32.

Myocardial energy depletion and dynamic systolic dysfunction in hypertrophic cardiomyopathy.

Ormerod JO, Frenneaux MP, Sherrid MV.

Nat Rev Cardiol. 2016 Nov;13(11):677-687. doi: 10.1038/nrcardio.2016.98. Epub 2016 Jul 14. Review.

PMID:
27411403
33.

Cardiac resynchronization therapy: mechanisms of action and scope for further improvement in cardiac function.

Jones S, Lumens J, Sohaib SMA, Finegold JA, Kanagaratnam P, Tanner M, Duncan E, Moore P, Leyva F, Frenneaux M, Mason M, Hughes AD, Francis DP, Whinnett ZI; BRAVO Investigators.

Europace. 2017 Jul 1;19(7):1178-1186. doi: 10.1093/europace/euw136.

34.

Assessment of the Physiological Adaptations to Chronic Hypoxemia in Eisenmenger Syndrome.

Bowater SE, Weaver RA, Beadle RM, Frenneaux MP, Marshall JM, Clift PF.

Congenit Heart Dis. 2016 Jul;11(4):341-7. doi: 10.1111/chd.12373. Epub 2016 May 19.

PMID:
27198869
35.

Response to Letter Regarding Article, "The Effect of Selective Heart Rate Slowing in Heart Failure With Preserved Ejection Fraction".

Pal N, Sivaswamy N, Mahmod M, Yavari A, Rudd A, Singh S, Dawson DK, Francis JM, Dwight JS, Watkins H, Neubauer S, Frenneaux M, Ashrafian H.

Circulation. 2016 Apr 19;133(16):e604. doi: 10.1161/CIRCULATIONAHA.116.021488. No abstract available.

PMID:
27142611
36.

Present and future pharmacotherapeutic agents in heart failure: an evolving paradigm.

Loudon BL, Noordali H, Gollop ND, Frenneaux MP, Madhani M.

Br J Pharmacol. 2016 Jun;173(12):1911-24. doi: 10.1111/bph.13480. Epub 2016 May 6. Review.

37.

The Authors Reply.

Dawson DK, Neil CJ, Henning A, Cameron D, Jagpal B, Bruce M, Horowitz J, Frenneaux MP.

JACC Cardiovasc Imaging. 2016 May;9(5):633. doi: 10.1016/j.jcmg.2015.02.032. Epub 2016 Feb 17. No abstract available.

38.

The Authors Reply.

Dawson DK, Neil CJ, Henning A, Cameron D, Jagpal B, Bruce M, Horowitz J, Frenneaux MP.

JACC Cardiovasc Imaging. 2016 May;9(5):635-6. doi: 10.1016/j.jcmg.2015.03.015. Epub 2016 Feb 17. No abstract available.

39.

The clinical outcome of cardiac resynchronization therapy in post-surgical valvular cardiomyopathy.

Leyva F, Umar F, Taylor RJ, Steeds RP, Frenneaux MP.

Europace. 2016 May;18(5):732-8. doi: 10.1093/europace/euv287. Epub 2016 Jan 22.

PMID:
26802014
40.

Right Ventricular Involvement and Recovery After Acute Stress-Induced (Tako-tsubo) Cardiomyopathy.

Scally C, Ahearn T, Rudd A, Neil CJ, Srivanasan J, Jagpal B, Horowitz J, Frenneaux M, Dawson DK.

Am J Cardiol. 2016 Mar 1;117(5):775-80. doi: 10.1016/j.amjcard.2015.11.057. Epub 2015 Dec 13.

PMID:
26782339
41.

Reference values for mitral and tricuspid annular dimensions using two-dimensional echocardiography.

Dwivedi G, Mahadevan G, Jimenez D, Frenneaux M, Steeds RP.

Echo Res Pract. 2014 Dec 1;1(2):43-50. doi: 10.1530/ERP-14-0050. Epub 2014 Sep 24.

42.

Remote monitoring in heart failure.

Frenneaux MP, Gollop ND, Loudon BL, Parasuraman S.

Eur Heart J Qual Care Clin Outcomes. 2015 Nov 1;1(2):45-46. doi: 10.1093/ehjqcco/qcv018. No abstract available.

PMID:
29474598
43.

T₁ mapping for assessment of myocardial injury and microvascular obstruction at one week post myocardial infarction.

Cameron D, Siddiqi N, Neil CJ, Jagpal B, Bruce M, Higgins DM, He J, Singh S, Redpath TW, Frenneaux MP, Dawson DK.

Eur J Radiol. 2016 Jan;85(1):279-285. doi: 10.1016/j.ejrad.2015.10.008. Epub 2015 Oct 23.

PMID:
26507864
44.

Stereoselective handling of perhexiline: implications regarding accumulation within the human myocardium.

Chong CR, Drury NE, Licari G, Frenneaux MP, Horowitz JD, Pagano D, Sallustio BC.

Eur J Clin Pharmacol. 2015 Dec;71(12):1485-91. doi: 10.1007/s00228-015-1934-8. Epub 2015 Sep 16.

PMID:
26376650
45.

Effect of Selective Heart Rate Slowing in Heart Failure With Preserved Ejection Fraction.

Pal N, Sivaswamy N, Mahmod M, Yavari A, Rudd A, Singh S, Dawson DK, Francis JM, Dwight JS, Watkins H, Neubauer S, Frenneaux M, Ashrafian H.

Circulation. 2015 Nov 3;132(18):1719-25. doi: 10.1161/CIRCULATIONAHA.115.017119. Epub 2015 Sep 2.

46.

Reply: Perhexiline, Cardiac Energetics, and Heart Failure: Lessons From the First Law of Thermodynamics.

Beadle RM, Frenneaux MP.

JACC Heart Fail. 2015 Aug;3(8):660. doi: 10.1016/j.jchf.2015.04.008. No abstract available.

47.

Short-term intravenous sodium nitrite infusion improves cardiac and pulmonary hemodynamics in heart failure patients.

Ormerod JO, Arif S, Mukadam M, Evans JD, Beadle R, Fernandez BO, Bonser RS, Feelisch M, Madhani M, Frenneaux MP.

Circ Heart Fail. 2015 May;8(3):565-71. doi: 10.1161/CIRCHEARTFAILURE.114.001716. Epub 2015 Apr 2.

48.

Role of aldehyde dehydrogenase in hypoxic vasodilator effects of nitrite in rats and humans.

Arif S, Borgognone A, Lin EL, O'Sullivan AG, Sharma V, Drury NE, Menon A, Nightingale P, Mascaro J, Bonser RS, Horowitz JD, Feelisch M, Frenneaux MP, Madhani M.

Br J Pharmacol. 2015 Jul;172(13):3341-52. doi: 10.1111/bph.13122. Epub 2015 Apr 29.

49.

Relation of delayed recovery of myocardial function after takotsubo cardiomyopathy to subsequent quality of life.

Neil CJ, Nguyen TH, Singh K, Raman B, Stansborough J, Dawson D, Frenneaux MP, Horowitz JD.

Am J Cardiol. 2015 Apr 15;115(8):1085-9. doi: 10.1016/j.amjcard.2015.01.541. Epub 2015 Jan 31.

PMID:
25724780
50.

Selection of magnetization catalyzation and readout methods for modified Look-Locker inversion recovery: a T1 mapping primer.

Cameron D, Higgins DM, Stehning C, Kouwenhoven M, Bouhrara M, Frenneaux MP, Dawson DK, Redpath TW.

Magn Reson Imaging. 2015 May;33(4):363-73. doi: 10.1016/j.mri.2015.02.004. Epub 2015 Feb 7.

PMID:
25660643

Supplemental Content

Loading ...
Support Center